OpportunityTitle: NeuroNEXT Infrastructure Resource Access (X01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Non-domestic (non-U.S.) Entities (Foreign Organizations) and components of U.S. organizations are eligible to apply, but will have to work with the U.S.-based NeuroNEXT infrastructure.   Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Description: This FOA encourages proposals for biomarker validation trials or exploratory clinical trials of drugs, biologics, surgical therapies or devices that may contribute to the justification for and provide the data required to design a future trial to confirm efficacy (i.e., a Phase III trial) in the treatment of neurologic disease. Proposals for drugs or biologics should provide compelling scientific evidence that the investigational agent proposed for study will reach/act upon the designated target or that its mechanism of action is such that it will be of benefit in ameliorating a specific aspect of the disease.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV &lt;br/&gt;